High Throughput Platform for Rapid Screening of Compounds on Over 3 000 Patients’ Derived Neurons in 30 Minutes

Time: 12:20 pm
day: Track A - Day 1 AM


  • Uncovering robust compound screening on patients’ derived neurons
  • Revealing rapid evaluation of compounds’ toxicity and efficacy in Alzheimer’s Disease models
  • Investigating phenotypic markers of degeneration and regeneration